Hepatitis A and E among immigrants and refugees in Central Brazil
DOI:
https://doi.org/10.11606/s1518-8787.2022056003839Palavras-chave:
Refugees, Latin America, Hepatitis A, epidemiology, Hepatitis E, epidemiology, Seroepidemiologic StudiesResumo
OBJECTIVE To estimate the prevalence of hepatitis A virus (HAV) and hepatitis E virus (HEV) among immigrants and refugees in Goiás, Central Brazil. METHODS Overall, 355 individuals were interviewed, and blood samples were tested for anti-HAV and anti-HEV IgG. Anti-HEV-positive samples were similarly tested for HEV RNA. RESULTS All participants were from Latin American countries, most of whom, young adult males. The overall anti-HAV IgG prevalence was 87.4% (95%CI: 83.5–90.4), of whom 94.9%, 75.6%, and 60% were from Haiti, Venezuela, and other Latin American countries, respectively (p < 0.001). Age above 19 years and more than 36 months residing in Brazil were associated with a higher prevalence of previous HAV and HEV infection, respectively. Of the children eligible for HAV vaccination according to the National Immunization Program, only eight (44%) had been vaccinated. The overall anti-HEV IgG prevalence was 6.5% (95%CI: 4.4–9.5). All anti-HEV IgG-positive individuals were Haitians, including a child born in Brazil. HEV RNA was detected in two of the anti-HEV IgG-positive samples. CONCLUSION The survey detected a high prevalence of anti-HAV and anti-HEV IgG among immigrants and refugees, and active HEV infection among some Haitian participants. Prevention measures are urgently required to interrupt enteric virus transmission in this emergent and vulnerable population.
Referências
United Nations High Commissioner for Refugees, Statistics and Demographics Section. Global Trends: forced displacement in 2019. Copenhagen (DK): UNHCR; 2020 [cited 2021 Aug 21]. Available from: https://www.unhcr.org/5ee200e37.pdf
United Nations. Total number of International migrants at mid-year 2020. New York: UN; 2020. Brazil: key migration statistics;Germany; 2020 [cited 2021 Aug 21]. Available from: https://migrationdataportal.org/data?i=stock_abs_&t=2020&cm49=76.
Ergönül O, Tülek N, Kayi I, Irmak H, Erdem O, Dara M. Profiling infectious diseases in Turkey after the influx of 3.5 million Syrian refugees. Clin Microbiol Infect Dis. 2020;26(3):307-12. https://doi.org/10.1016/j.cmi.2019.06.022
Savage RD, Rosella LC, Crowcroft NS, Horn M, Khan K, Varia M. Accuracy of health administrative data to identify cases of reportable travel or migration-related infectious diseases in Ontario, Canada. PLoS One. 2018;13(11):e0207030. https://doi.org/10.1371/journal.pone.0207030
Abutaleb A, Kottilil S. Hepatitis A: epidemiology, natural history, unusual clinical manifestations, and prevention. Gastroenterol Clin North Am. 2020;49(2):191-9. https://doi.org/10.1016/j.gtc.2020.01.002
Goel A, Aggarwal R. Hepatitis E: epidemiology, clinical course, prevention, and treatment. Gastroenterol Clin North Am. 2020;49(2):315-30. https://doi.org/10.1016/j.gtc.2020.01.011
Lagare A, Ibrahim A, Ousmane S, Issaka B, Zaneidou M, Kadadé G, et al. Outbreak of Hepatitis E virus infection in displaced persons camps in Diffa Region, Niger, 2017. Am J Trop Med Hyg. 2018;99(4):1055-7. https://doi.org/10.4269/ajtmh.17-0950
Mellou K, Chrisostomou A, Sideroglou T, Georgakopoulou T, Kyritsi M, Hadjichristodoulou C, et al. Hepatitis A among refugees, asylum seekers and migrants living in hosting facilities, Greece, April to December 2016. Euro Surveill. 2017;22(4):30448. https://doi.org/10.2807 / 1560-7917.ES.2017.22.4.30448
Cooper BS, White LJ, Siddiqui R. Reactive and pre-emptive vaccination strategies to control hepatitis E infection in emergency and refugee settings: a modelling study. PLoS Negl Trop Dis. 2018;12(9):e0006807. https://doi.org/10.1371/journal.pntd.0006807
Kloning T, Nowotny T, Alberer M, Hoelscher M, Hoffmann A, Froeschl G. Morbidity profile and sociodemographic characteristics of unaccompanied refugee minors seen by paediatric practices between October 2014 and February 2016 in Bavaria, Germany. BMC Public Health. 2018;18(1):983. https://doi.org/10.1186/s12889-018-5878-7
Castelli F, Sulis G. Migration and infectious diseases. Clin Microbiol Infect Dis. 2017;23(5):283-9. https://doi.org/10.1016/j.cmi.2017.03.012
International Committee on Taxonomy of Viruses. Genus: Hepatovirus. Berlin (DE): ICTV; 2018.
Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology. 2012;55(4):988-97. https://doi.org/10.1002/hep.25505
World Organization Health. Meeting on the Strategic Advisory Group of experts on immunization, October 2014: conclusions and recommendations. Wkly Epidemiol Rec. 2014;89(50):561-76.
Melgaço JG, Gardinali NR, Mello VM, Leal M, Lewis-Ximenez LL, Pinto MA. Hepatitis E: update on prevention and control. Biomed Res Int. 2018;2018:5769201. https://doi.org/10.1155/2018/5769201
World Organization Health. Hepatitis A vaccine: WHO position. Wkly Epidemiol Rec. WHO; 2000;75(5):37-44.
Ximenes RAA, Martelli CMT, Amaku M, Sartori AMC, Soárez PC, Novaes HMD, et al. Modelling the force of infection for hepatitis A in an urban population-based survey: a comparison of transmission patterns in Brazilian macro-regions. PLoS One. 2014;9(5):e94622. https://doi.org/10.1371/journal.pone.0094622
Ministério da Saúde (BR), Secretaria de Vigilância em Saúde, Departamento de Vigilância das Doenças Transmissíveis, Coordenação-Geral do Programa Nacional de Imunizações. Nota Informativa Nº 384, de 2016/CGPNI/DEVIT/SVS/MS. Informa as mudanças no Calendário Nacional de Vacinação para o ano de 2017. Brasília, DF; 2016 [cited 2021 Aug 21]. Available from: http://www.sgc.goias.gov.br/upload/arquivos/2017-01/nota-inf-384_-sem-anexos.pdf
Tengan FM, Figueiredo GM, Nunes AKS, Manchiero C, Dantas BP, Magri MC, et al. Seroprevalence of hepatitis E in adults in Brazil: a systematic review and meta-analysis. Infect Dis Poverty. 2019;8:3. https://doi.org/10.1186/s40249-018-0514-4
Instituto Brasileiro de Geografia e Estatística. Cidades e Estados. Rio de Janeiro: IBGE; 2020.
Instituto Brasileiro de Geografia e Estatística. Panorama Cidades – Goiânia. Rio de Janeiro: IBGE; c2017 [cited 2021 Aug 21]. Available from: https://cidades.ibge.gov.br/brasil/go/goiania/panorama
International Organization for Migration. International Migration Law- Glossary on Migration nº 34. Geneva (CH): IOM; 2019 [cited 2021 Aug 21]. Available from:
https://publications.iom.int/system/files/pdf/iml_34_glossary.pdf
Alto Comissariado das Nações Unidas para Refugiados. Refugiado ou migrante? O ACNUR incentiva a usar o termo correto. Genebra (CH); 2015 [cited 2021 Aug 21]. Available from: https://www.acnur.org/portugues/2015/10/01/refugiado-ou-migrante-o-acnur-incentiva-a-usar-o-termo-correto/
Horvatits T, Ozga AK, Westholter D, Hartl J, Manthey CF, Lutgehetmann M, et al. Hepatitis E seroprevalence in the Americas: a systematic review and meta-analysis. Liver Int. 2018;38(11):1951-64. https://doi.org/10.1111/liv.13859
Santos DRL, Paula VS, Oliveira JM, Marchevsky RS, Pinto MA. Hepatitis E virus in swine and effluent samples from slaughterhouses in Brazil. Vet Microbiol. 2011;149(1-2):236-41. https://doi.org/10.1016/j.vetmic.2010.10.024
Cavalcanti L, Oliveira T, Macêdo M, Pereda L. Imigração e refúgio no Brasil: Relatório Anual do Observatório das Migrações Internacionais 2019. Brasília, DF: Ministério da Justiça e Segurança Pública; 2019. (Série Migrações).
Cavalcanti L, Tonhati T, Araújo D, Brasil E, Oliveira T. Haitian immigrants in the Brazilian labour market: an overview. Rev Est Pesq Am. 2017;11(1):192-203. https://doi.org/10.21057/repam.v11i1.25452
Andani A, Elten TM, Bunge EM, Marano C, Salgado F, Jacobsen KH. Hepatitis A epidemiology in Latin American countries: a 2020 view from a systematic literature review. Expert Rev Vaccines. 2020;19(9):795-805. https://doi.org/10.1080/14760584.2020.1813575
Naewiger M, Struck F, Lüttich S, Uzun S, Nölting C, Krämer B, et al. Hepatitis E virus ELISA and Line Immunoassy for diagnosis of Acute HEV infections. In. 26. European Congress of Clinical Microbiology and Infections Diseases;9-12 April 2016; Amsterdam, Netherlands.
Tejada-Strop A, Tohme RA, Andre-Alboth J, Childs L, Ji X, Castro VOL, et al. Seroprevalence of Hepatitis A and Hepatitis E viruses among pregnant women in Haiti. Am J Trop Med Hyg. 2019;101(1):230-2. https://doi.org/10.4269/ajtmh.19-0020
Oliveira JMNS, Freitas NR, Teles SA, Bottino FO, Lemos AS, Oliveira JM, et al. Prevalence of hepatitis E virus RNA and antibodies in a cohort of kidney transplant recipients in Central Brazil. Int J Infect Dis. 2018;69:41-3. https://doi.org/10.1016/j.ijid.2018.01.032
Araújo DCE, Oliveira JM, Haddad SK, Roza DL, Bottino FO, Faria SBSC, et al. Declining prevalence of hepatitis A and silent circulation of hepatitis E virus infection in southeastern Brazil. Int J Infect Dis. 2020;101:17-23. https://doi.org/10.1016/j.ijid.2020.09.024
Pan American Health Organization. Hepatitis Vaccines. Available from: https://www.paho.org/en/tag/hepatitis-vaccines
Downloads
Publicado
Edição
Seção
Licença
Copyright (c) 2022 Grazielle Rosa da Costa e Silva, Thaynara Lorrane Silva Martins, Carla de Almeida Silva, Karlla Antonieta Amorim Caetano, Megmar Aparecida dos Santos Carneiro, Bruno Vinicius Diniz e Silva, Leonora Rezende Pacheco, Livia Melo Villar, Vanessa Salete de Paula, Regina Maria Bringel Martins, Sheila Araújo Teles
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Como Citar
Dados de financiamento
-
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Números do Financiamento 424313/2018-9 -
Fundação de Amparo à Pesquisa do Estado de Goiás
Números do Financiamento public call 04/2017